Fabrication of hydrophobic drug-loaded Zeolitic Imidazolate Framework-8 (ZIF-8) for enhanced anti-bacterial activity

Current study presents a novel approach for constructing small hydrophobic biomolecules embedded within zeolitic imidazolate framework-8 (ZIF-8) with exceptional antibacterial properties. In this method, ZIF-8 is synthesized from zinc acetate and 2-methylimidazole in the presence or absence of small hydrophobic bioactive molecules like rutin, rosmarinic acid, and morin. Scanning electron microscopy (SEM) analysis reveals that the synthesized ZIF-8 nanoparticles exhibit mostly hexagonal shape with size 200 nm which is further increased upon drug encapsulation. The synthesis of ZIF-8 and drug-loaded ZIF-8 is confirmed through FTIR, UV-vis spectroscopy, XRD, TGA, and EDX analyses. Zeta potential measurements show values ranging from -14.5 to -23.97 mV for both ZIF-8 and drug-loaded ZIF-8 nanoparticles. The drug loading content is determined to be 5%, 9%, and 16% for morin, rutin, and rosmarinic acid, respectively. All the drug-loaded ZIF-8 formulations exhibit a pH-dependent drug release pattern, with maximal drug release observed at lower pH levels. Most importantly, these formulations demonstrate potent antibacterial activity against both Gram-positive (Enterococcus faecalis and Bacillus subtilis) and Gram-negative (Escherichia coli) bacterial strains. Specifically, ZIF-8/RUT exhibit maximum zone of inhibition (ZOI ∼ 51 mm) against all tested bacterial strains. ZIF-8/MOR and ZIF-8/RUT exhibit MIC values ranging from 2.0 to 3.0 mg/mL and MBC values from 6 to 9 mg/mL against all the tested bacteria. Among the formulations, ZIF-8/MOR and ZIF-8/RUT exhibit synergistic antibacterial effect, whereas ZIF-8/RMA possess less antibacterial potency against all the tested bacteria and mostly exhibit additive effect. Our findings suggest that these newly developed nano-formulations hold potential for the creation of highly effective antibacterial agents.